CSP: A Comparison of the Resection Rate of Cold Snare Polypectomy for Large (10-15 mm) and Small (5-9 mm) Colorectal Polyps

Sponsor
Yuqi He (Other)
Overall Status
Completed
CT.gov ID
NCT03647176
Collaborator
(none)
1,000
1
2
17
59

Study Details

Study Description

Brief Summary

Colorectal cancer remains the third most common cause of death from cancer worldwide. Colonoscopy allows removal of adenomatous polyps is the best colorectal cancer screening, according to the adenoma-carcinoma sequence. Recent studies have reported approximately 30% of interval cancer may be incomplete polyp resection. Complete polyp resection may be particularly important when implementing new methods for surveillance colonoscopies. Cold snare polypectomy (CSP) is considered to be a safer procedure for removing subcentimeter lesions than conventional hot snare polypectomy (HSP). CSP removal of polyps sized ≤5 mm have recommended by the European Society of Gastrointestinal Endoscopy guideline as the preferred technique. Previous report said that the complete resection rate of CSP for adenomatous polyps 4-9 mm in size was comparable to that of HSP, and in the foreseeable future CSP can be one of the standard techniques for 4-9 mm colorectal polyps. However, data on complete resection of colorectal polyps 1.0-1.5 mm in size is sparse. Investigators are interested in comparison of the resection rate of cold snare polypectomy for large (10-15 mm) and small (5-9 mm) colorectal polyps using CSP.

Condition or Disease Intervention/Treatment Phase
  • Other: Cold snare polypectomy
N/A

Detailed Description

Participantswho meet inclusion criteria will be asked to participate, investigators will include all patients with resectable polyps, but only adenomatous polyps will be included for analysis. See also inclusion and exclusion criteria.

Colonoscopy, after bowel preparation with polyethylene glycol solution was performed using standard colonoscopes (CF-HQ290I, CF-Q260AI) and polypectomy snares(13mm Captivator and 10mm Captivator II).

All procedures were performed by experienced endoscopists (each with over 1000 colonoscopies performed) including CSP. All polyps between 5 and 15mm will be removed with a polypectomy snare. Polyp size will be measured using the tip of the snare catheter (2.5mm). Difficulty of resection will be grade by polyp resection time. Following the resection, jet stream of water will be used to wash mucosal defect thoroughly. After endoscopist's attestation that polyp removal was complete by carefully observe the resection margins with near focus mode, for large lesions (10-15mm) 4 biopsies will be performed from all four quadrants of resection margins, for small lesions (5-9mm) biopsies were performed from two marginal sites located symmetrically on the left and right of the mucosal defects to confirm residual polyp tissue.

If polyp resection is complicated by bleeding (not self-sustained), no biopsies will be taken and any additional polyps that will be found during the remaining examination will be excluded from analysis. Severe bleeding that will complicate resection margins examination will be excluded from analysis, Endoscopic haemostasis will be performed when active haemorrhage continued for ≥30s.

A single research subject may have many eligible polyps. To avoid taking many biopsies, the investigators will not include more than 5 eligible polyps (the first 5 that are detected) per patient in the study.

Laboratory Analysis:

The polyps will be evaluated by experienced pathologists according to Vienna classification. Resection margins for each polyp will be recorded as: R0= adenomatous tissue free, R1=adenomatous tissue detection. Investigators will only include adenomatous polyps in the analysis. for financial requests of the resection margin biopsies. The pathological diagnosis of the biopsies will become part of the medical record. If biopsies contain adenomatous tissue the participants will be ask to return for a follow-up colonoscopy within six month.

Study Design

Study Type:
Interventional
Actual Enrollment :
1000 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
PLA Army General Hospital of Beijing
Actual Study Start Date :
Sep 3, 2018
Actual Primary Completion Date :
Jan 15, 2020
Actual Study Completion Date :
Feb 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: small polyps

Cold snare polypectomy ; Polyp size will be measured using the tip of the snare catheter (2.5mm).Small (5-9 mm) colorectal polyps will be removed with a polypectomy snare. Following the resection, jet stream of water will be used to wash mucosal defect thoroughly. After endoscopist's attestation that polyp removal was complete by carefully observe the resection margins with near focus mode, biopsies were performed from two marginal sites located symmetrically on the left and right of the mucosal defects to confirm residual polyp tissue.

Other: Cold snare polypectomy
cold snare polypectomy (CSP), which does not include electrocautery to do a polypectomy with a snare

Experimental: large polyps

Cold snare polypectomy; Polyp size will be measured using the tip of the snare catheter (2.5mm). Large (10-15 mm) colorectal polyps will be removed with a polypectomy snare. Following the resection, jet stream of water will be used to wash mucosal defect thoroughly. After endoscopist's attestation that polyp removal was complete by carefully observe the resection margins with near focus mode, 4 biopsies will be performed from all four quadrants of resection margins.

Other: Cold snare polypectomy
cold snare polypectomy (CSP), which does not include electrocautery to do a polypectomy with a snare

Outcome Measures

Primary Outcome Measures

  1. incomplete CSP resection rate of neoplastic polyps and subgroup analyses of possible factors that could contribute to an incomplete resection [six months]

    Incomplete resection was presence of neoplastic tissue from histopathologic examination of polyp margin biopsies. Subgroup included polyp size (5-7mm/8 -9mm/10 -15mm), location (right/left side was defined proximal/distal to the splenic flexure), location with respect to colonic folds (between/on the fold or not), flat morphology (measured by the tip of the 2.4-mm snare catheter), en bloc vs piecemeal resection, a snare exclusively designed as a cold snare versus traditional polypectomy snare, Neoplastic polyps( Adenoma, sessile serrated adenomas/polyps, high-grade dysplasia), and ease of polyp resection (easy or 30s; moderately difficult or 30-60s, difficult or 60s).

Secondary Outcome Measures

  1. polypectomy procedure times [six months]

    Time required for resection was defined as the time between the insertion of the snare into working channel to the end of polyp resection

  2. the rates of procedure-related complications [six months]

    Delayed bleeding was defined as haemorrhage after colonoscopy requiring endoscopic haemostasis;submucosal disruption; perforation

Other Outcome Measures

  1. adequate assessment of the polyp lateral or vertical margin [1 year]

    Pathological assessment

  2. margins assess after resection [1 year]

    narrow band imaging to delineate polyp margins

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years to 85 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Patient ≥40 and <85

  • Provide written informed consent

  • Patients are found to have colorectal polyps between 5 and 15mm in size

Exclusion Criteria:
  • History of inflammatory bowel disease

  • Polyposis of the alimentary tract

  • Antiplatelet or anticoagulant therapy 5 days before the procedure

  • Pregnancy

  • Haemodialysis

  • An American Society of Anaesthesiologists class III or higher

  • Depressed lesions and lesions highly suspected to be cancerous based on endoscopic appearance

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Gastroenterology, PLA Army General Hospital Beijing Dongcheng District China 100700

Sponsors and Collaborators

  • Yuqi He

Investigators

  • Principal Investigator: tianyang zhang, Medical department

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yuqi He, Principal Investigator, Clinical Professor, General Hospital of Beijing PLA Military Region
ClinicalTrials.gov Identifier:
NCT03647176
Other Study ID Numbers:
  • PLA GH-CSP-1
First Posted:
Aug 27, 2018
Last Update Posted:
Mar 2, 2020
Last Verified:
Feb 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Yuqi He, Principal Investigator, Clinical Professor, General Hospital of Beijing PLA Military Region
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 2, 2020